Research Paper Volume 13, Issue 12 pp 16541—16566
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
Figure 5. FGFR3 mutation classification according to clinical therapeutic implications. (A) FGFR3 mutations were classified according to the therapeutic implications defined by OncoKB among all tumors together. (B) Therapeutic implications class distribution of FGFR3 mutations in pan-cancer and the top ten tumor types.